IRIS Accounts Production v24.3.0.553 11461741 director 1.8.23 31.7.24 31.7.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh114617412023-07-31114617412024-07-31114617412023-08-012024-07-31114617412022-07-31114617412022-08-012023-07-31114617412023-07-3111461741ns15:EnglandWales2023-08-012024-07-3111461741ns14:PoundSterling2023-08-012024-07-3111461741ns10:Director12023-08-012024-07-3111461741ns10:PrivateLimitedCompanyLtd2023-08-012024-07-3111461741ns10:SmallEntities2023-08-012024-07-3111461741ns10:AuditExempt-NoAccountantsReport2023-08-012024-07-3111461741ns10:SmallCompaniesRegimeForDirectorsReport2023-08-012024-07-3111461741ns10:SmallCompaniesRegimeForAccounts2023-08-012024-07-3111461741ns10:AbridgedAccounts2023-08-012024-07-311146174112023-08-012024-07-3111461741ns10:RegisteredOffice2023-08-012024-07-3111461741ns5:CurrentFinancialInstruments2024-07-3111461741ns5:CurrentFinancialInstruments2023-07-3111461741ns5:Non-currentFinancialInstruments2024-07-3111461741ns5:Non-currentFinancialInstruments2023-07-3111461741ns5:ShareCapital2024-07-3111461741ns5:ShareCapital2023-07-3111461741ns5:RetainedEarningsAccumulatedLosses2024-07-3111461741ns5:RetainedEarningsAccumulatedLosses2023-07-3111461741ns5:IntangibleAssetsOtherThanGoodwill2023-08-012024-07-3111461741ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2023-08-012024-07-3111461741ns5:ComputerSoftware2023-08-012024-07-3111461741ns5:PlantMachinery2023-08-012024-07-31
REGISTERED NUMBER: 11461741 (England and Wales)















LINCSTHERAPY LTD

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JULY 2024






LINCSTHERAPY LTD (REGISTERED NUMBER: 11461741)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024




Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 4


LINCSTHERAPY LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 JULY 2024







DIRECTOR: B J Pope





REGISTERED OFFICE: 64 St. Peters Avenue
Cleethorpes
North East Lincolnshire
United Kingdom
DN35 8HP





REGISTERED NUMBER: 11461741 (England and Wales)





ACCOUNTANTS: Jane Maynard Limited
T/A Maynard Johns
37 Mill Street
Bideford
DEVON
EX39 2JJ

LINCSTHERAPY LTD (REGISTERED NUMBER: 11461741)

ABRIDGED BALANCE SHEET
31 JULY 2024

2024 2023
Notes £    £   
FIXED ASSETS
Intangible assets 4 768 925
Tangible assets 5 2,684 4,804
3,452 5,729

CURRENT ASSETS
Debtors 7,410 7,345
Cash at bank and in hand 10,548 11,297
17,958 18,642
CREDITORS
Amounts falling due within one year (6,172 ) (8,847 )
NET CURRENT ASSETS 11,786 9,795
TOTAL ASSETS LESS CURRENT
LIABILITIES

15,238

15,524

CREDITORS
Amounts falling due after more than one
year

(1,100

)

(2,015

)

PROVISIONS FOR LIABILITIES (82 ) (391 )
NET ASSETS 14,056 13,118

CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings 14,055 13,117
SHAREHOLDERS' FUNDS 14,056 13,118

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

LINCSTHERAPY LTD (REGISTERED NUMBER: 11461741)

ABRIDGED BALANCE SHEET - continued
31 JULY 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Income Statement and an abridged Balance Sheet for the year ended 31 July 2024 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 11 November 2024 and were signed by:





B J Pope - Director


LINCSTHERAPY LTD (REGISTERED NUMBER: 11461741)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024

1. STATUTORY INFORMATION

Lincstherapy Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Trademarks are being amortised evenly over their estimated useful life of ten years.

Computer software is being amortised evenly over its estimated useful life of three years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33% on cost and 20% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

LINCSTHERAPY LTD (REGISTERED NUMBER: 11461741)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JULY 2024

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

4. INTANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 August 2023
and 31 July 2024 7,060
AMORTISATION
At 1 August 2023 6,135
Amortisation for year 157
At 31 July 2024 6,292
NET BOOK VALUE

At 31 July 2024 768
At 31 July 2023 925

5. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 August 2023 11,878
Additions 59
Disposals (250 )
At 31 July 2024 11,687
DEPRECIATION
At 1 August 2023 7,074
Charge for year 2,179
Eliminated on disposal (250 )
At 31 July 2024 9,003
NET BOOK VALUE
At 31 July 2024 2,684
At 31 July 2023 4,804